Loading...
OTCM
REMI
Market cap13kUSD
Jul 09, Last price  
0.00USD
Jan 2017
-99.59%
IPO
-99.56%
Name

Remedent Inc

Chart & Performance

D1W1MN
OTCM:REMI chart
P/E
P/S
0.01
EPS
Div Yield, %
Shrs. gr., 5y
0.74%
Rev. gr., 5y
-9.27%
Revenues
986k
+14.17%
7,072,3007,393,9486,676,3657,482,26114,639,5418,247,94012,581,7089,687,2922,937,2762,592,5963,616,3552,770,0922,355,7062,699,8551,603,7411,064,4191,029,9061,407,661863,819986,220
Net income
-274k
L-81.64%
-103,428-3,887,302-1,496,049-3,115,513-2,952,915-2,349,915-1,547,175490,483-981,936524,508105,159160,802844,370-54,5912,128,796-854,267-163,100-257,182-1,494,837-274,446
CFO
-131k
L+145.91%
583,730-3,013,455-659,307-2,445,011-880,489232,885-135,226-109,777-946,316-103,939300,568-203,1131,668,96020,327567,618101,5481,721-168,948-53,072-130,512

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Remedent, Inc., operating through its various subsidiaries, specializes in the research, development, manufacturing, and distribution of products for both oral hygiene and aesthetic dentistry. The company's core offerings include professional-grade dental veneers and teeth whitening systems, designed for use by dental practitioners as well as for over-the-counter purchase by consumers. Its innovative product portfolio features River8, a pre-fabricated veneer solution that assists dentists in achieving optimal tooth alignment with minimal patient tooth reshaping. Additionally, Remedent supplies GlamSmile veneers, which are exceptionally thin shells bonded to the front surfaces of a patient's teeth. Beyond physical products, the company offers a suite of digital tools and services aimed at enhancing dental practice operations. These include the SmileMe Mirror, an integrated marketing concept that enables quick smile consultations in about ten minutes; SmileSketch, simulation software capable of creating visual previews of potential aesthetic results; and various "Treatment Pages" designed to explain the advantages of specific dental procedures. Furthermore, Remedent provides the Condor, an advanced intra-oral 3D scanning device. The company's expertise also extends to dental implant technologies and related treatment methodologies. Remedent distributes its products to dental professionals in nearly 30 countries, spanning regions such as Asia, Europe, the Middle East, Canada, and the United States, utilizing both its internal sales team and third-party distributors. Founded in 1986, the company's corporate headquarters are located in Ghent, Belgium.
IPO date
Sep 20, 2001
Employees
3
Domiciled in
BE
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT